Hypoglycemia Associated With Drug-Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors

• Váldodahkkit: Chin-Ying Ray (Dahkki), Victor Chien-Chia Wu (Dahkki), Chun-Li Wang (Dahkki), Hui-Tzu Tu (Dahkki), Yu-Tung Huang (Dahkki), Chang-Fu Kuo (Dahkki), Shang-Hung Chang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Dipeptidylpeptidase-4 inhibitors (DPP-4i's) are considered to be safe for patients with type 2 diabetes mellitus (T2DM). However, little is known about drug-drug interactions between DPP-4i's and concurrent medications.Methods: Data on patients using DPP-4i's for T2DM duri...